← Leaderboards
Anna Louise Gloyn
University Of Oxford
$5,815,712
Attributed
$23,002,566
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2019–25$10M$7.5M$5M$2.5M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,002,566 · 6
By mechanism
UM1$9,505,667 · 1
U01$6,861,603 · 2
U24$3,713,324 · 1
RC2$1,620,238 · 1
R01$1,301,734 · 1
Top collaborators
- Mark A Atkinson6 shared
- Rita Bottino6 shared
- Marcela Brissova6 shared
- Dirk Homann6 shared
- Seung K Kim6 shared
- Patrick Macdonald6 shared
- Karen L Mohlke6 shared
- Stephen Cj Parker6 shared
Most similar at University Of Oxford
Same institution · by research overlap
- Mark Ian McCarthy$9,157,229
- Juliana Cn Chan$305,896
- Shah Brian Ebrahim$305,896
- Philippe Froguel$305,896
- Weiping Jia$305,896
Others in their field
Other Emerging Leaders on “Functional Disorder”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Susan M Landau · University Of California Berkeley$47,252,026
- Evan Z Macosko · Broad Institute, Inc.$28,495,187
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Barbara Halina Braffett · George Washington University$22,016,904
Research focus
Functional DisorderTissuesResearch PersonnelCommunitiesInsulin SecretionIsletNon-Insulin-Dependent Diabetes MellitusMolecularCellsInsulinHuman GeneticsBeta CellPharmaceutical PreparationsProgramsClinical PhenotypeDiabetes MellitusImpairmentCell TypeGenerationsInsightCollaborationsIslets Of LangerhansGenesBiology
Grant awards (18)
An interactive resource to generate and provide integrated knowledge of the human pancreas$1,993,904
U24 · FY2025 · DK
Resources to interpret genetic signals and multi-tissue mechanisms for type 2 diabetes and related traits$1,620,238
RC2 · FY2025 · DK
Deep Mutational Scanning of Monogenic Diabetes Genes to Facilitate Precision Diagnostics for Diabetes$657,261
R01 · FY2025 · DK · contact PI
Bridging the gap between type 2 diabetes GWAS and therapeutic targets$1,767,978
UM1 · FY2024 · DK
An interactive resource to generate and provide integrated knowledge of the human pancreas$1,719,420
U24 · FY2024 · DK
Human Pancreas Analysis Program-T2D$1,055,999
U01 · FY2024 · DK
Deep Mutational Scanning of Monogenic Diabetes Genes to Facilitate Precision Diagnostics for Diabetes$644,473
R01 · FY2024 · DK · contact PI
Bridging the gap between type 2 diabetes GWAS and therapeutic targets$1,863,743
UM1 · FY2023 · DK
Human Pancreas Analysis Program-T2D$1,100,000
U01 · FY2023 · DK
Human Pancreas Analysis Program-T2D$350,000
U01 · FY2023 · DK
Bridging the gap between type 2 diabetes GWAS and therapeutic targets$1,899,761
UM1 · FY2022 · DK
Human Pancreas Analysis Program-T2D$1,100,000
U01 · FY2022 · DK
Bridging the gap between type 2 diabetes GWAS and therapeutic targets$1,948,933
UM1 · FY2021 · DK
Bridging the gap between type 2 diabetes GWAS and therapeutic targets$2,025,252
UM1 · FY2020 · DK
Human Pancreas Analysis Program-T2D$1,100,000
U01 · FY2020 · DK
Human Pancreas Analysis Program-T2D$1,899,738
U01 · FY2019 · DK
Integrating genome-scale data to reveal causal mechanisms in type 2 diabetes$255,865
U01 · FY2019 · DK · contact PI
Integrating genome-scale data to reveal causal mechanisms in type 2 diabetes$1
U01 · FY2019 · DK · contact PI